Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.
about
Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: a phase I study.Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis
P2860
Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nimotuzumab Combined with Chem ...... Metastatic Esophageal Cancer.
@en
Nimotuzumab Combined with Chem ...... Metastatic Esophageal Cancer.
@nl
type
label
Nimotuzumab Combined with Chem ...... Metastatic Esophageal Cancer.
@en
Nimotuzumab Combined with Chem ...... Metastatic Esophageal Cancer.
@nl
prefLabel
Nimotuzumab Combined with Chem ...... Metastatic Esophageal Cancer.
@en
Nimotuzumab Combined with Chem ...... Metastatic Esophageal Cancer.
@nl
P2093
P2860
P356
P1476
Nimotuzumab Combined with Chem ...... d Metastatic Esophageal Cancer
@en
P2093
Jianming Xu
Xinghua Han
Yueyin Pan
P2860
P304
P356
10.12659/MSM.902645
P577
2017-01-24T00:00:00Z